Medtronic: FDA clears LigaSure RAS Maryland on Hugo RAS system

Source excerpt

Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system News provided by Medtronic plc Sep 16, 2026, 06:30 ET Share this article Share to X Share this article Share to X Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland , Sept. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT ), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system. The clearance expands the instruments available on the Hugo RAS system and brings Medtronic's trusted vessel-sealing technology to U.S. surgeons performing robotic-assisted procedures. Continue Reading The U.S. FDA has cleared the LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system. LigaSure™ technology has been used in more than 45 million surgical procedures worldwide. As robotic-assisted surgery adoption grows in the U.S., surgeons increasingly expect the same trusted energy instruments in a robotic workflow that they rely on in open and laparoscopic settings. The LigaSure RAS Maryland instrument meets that expectation, pairing a versatile robotic platform with vessel-sealing technology surgeons alr

Company press release